Log in with your email address username.

×

Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

Controversy grows over redefinition of gestational diabetes

- Featured Image

To the Editor: Moynihan has recently suggested that gestational diabetes mellitus (GDM) is a “non-entity”1 and cited controversy regarding new diagnostic criteria, while McIntyre and Oats have defended the practice of screening for GDM.2 Robust data associate hyperglycaemia with adverse pregnancy outcomes;3 and randomised controlled trial data show a beneficial effect of screening and treatment on perinatal outcomes.4

However, it is short-sighted to consider only the immediate outcome of a pregnancy. GDM has very significant long-term consequences for mothers and their offspring. Half of all women diagnosed with GDM will later develop type 2 diabetes, and they also bear a substantially increased risk of future cardiovascular disease.5 Identification of GDM therefore provides an opportunity to intervene with a view to improving the long-term health of young women who are at risk. Furthermore, in-utero hyperglycaemia seems to cause fetal programming effects which increase the risk of type 2 diabetes in offspring — additive to the genetic transmission of diabetogenic traits from mother to child.

The newly proposed International Association…

email